BlackRock Health Sciences Trust
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in BME.
▼ -6.6% over 5Y.
today you would have $1,314.82▲ +31.5%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $41.13 | $37.93 | $40.46 | $43.58 | |
| P/E | — | — | 23.3x | 28.1x | — |
| P/S | 20.9x | 6.9x | 20.9x | 27.6x | — |
| P/B | 0.9x | 0.9x | 0.9x | 1.0x | 1.0x |
| EPS | — | $1.63 |
Not shown for closed-end funds and BDCs. The methods assume operating profit, and a fund’s earnings per share are capital gains on its portfolio plus interest income — running them through Graham or a discounted cash flow produces a number that looks like a valuation and means nothing. What matters for a fund is its price against net asset value, which this site does not track.
Companies of similar size in Financial Services, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| AFJKAimei Health Technology Co., Ltd. | $12.10 | 172.9x | — | — | — | $38.31M |
| AEAQActivate Energy Acquisition Corp. | $10.10 | — | — | — | — | $316.25M |
| AESPAeon Acquisition I Corp. | $9.98 | — | — | — | — | $213.35M |
| APMCAmperCap Acquisition Co | $9.98 |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Company description provided by Yahoo Finance.
| $1.44 |
| -$2.10 |
| Dividend yield | 6.59% | 7.64% | 6.87% | 6.32% | 5.87% |
| Payout | — | — | 159.82% | 177.50% | — |
| Profit margin | 98.67% | 99.27% | 97.44% | 98.07% | 101.93% |
| ROE | 3.85% | 13.54% | 4.29% | 3.40% | -4.41% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 255.9x |
| — |
| — |
| $199.19M |
| AXINAxiom Intelligence Acquisition Corp 1 | $10.33 | — | — | — | — | $350.53M |
| ABTCAmerican Bitcoin Corp. | $8.84 | — | 1.0x | — | -38.53% | $1.08B |